<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722979</url>
  </required_header>
  <id_info>
    <org_study_id>2017/179/HP</org_study_id>
    <nct_id>NCT03722979</nct_id>
  </id_info>
  <brief_title>Study of the Expression of Endoplasmic Reticulum Stress During Extracorporeal Circulation in Humans</brief_title>
  <acronym>STRECH</acronym>
  <official_title>Study of the Expression of Endoplasmic Reticulum Stress During Extracorporeal Circulation in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The links between systemic inflammation, endothelial dysfunction and endoplasmic reticulum&#xD;
      (ER) stress in pre-clinical models make it an interesting potential therapeutic target, but&#xD;
      there are no data describing SRE during severe inflammation in humans .&#xD;
&#xD;
      For an approach to the study of SRE in humans in a situation of systemic inflammation, the&#xD;
      analysis of patients benefiting from an extra-corporeal circulation for a programmed cardiac&#xD;
      surgery would allow a study under well described conditions of inflammation, standardized,&#xD;
      with the possibility for each patient to be his own witness. Compared to a situation of&#xD;
      secondary inflammation (sepsis, acute pancreatitis, trauma ...) the analysis of the patients&#xD;
      under CEC allows more precise description of the kinetics of the activation of the SRE&#xD;
      because the beginning of the inflammatory mechanism is known with precision.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">August 9, 2018</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Study of the variation of a marker of endoplasmic reticulum stress, between the pre- extracorporeal circulation (CEC) sample and the sample taken 2 hours after the release of extracorporeal circulation</measure>
    <time_frame>2 hours after the release of extracorporeal circulation</time_frame>
    <description>ELISA technique (comparison of protein levels) + quantitative RT-PCR (comparison of normalized mRNA expression concentrations relative to a control gene).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">53</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>All patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac surgery</intervention_name>
    <description>The study will enroll patients having a planned cardiac surgery under extracorporeal circulation (CEC)</description>
    <arm_group_label>All patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Major patient (age ≥ 18 years)&#xD;
&#xD;
          -  Patient undergoing cardiac surgery under extracorporeal circulation (duration of&#xD;
             planned CEC &gt; 1h)&#xD;
&#xD;
          -  Informed person, having read and signed his consent preoperatively no later than the&#xD;
             day before the procedure.&#xD;
&#xD;
          -  Person affiliated with a social security scheme&#xD;
&#xD;
          -  Effective contraception in women of childbearing potential. For menopausal women, the&#xD;
             diagnosis of menopause will be based on the gynecological history of the patient (age&gt;&#xD;
             50 years + amenorrhea for more than 12 months).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with urgent cardiac surgery&#xD;
&#xD;
          -  Patient with cardiac surgery without extracorporeal circulation&#xD;
&#xD;
          -  Patient with surgery under &quot;mini-CEC&quot;&#xD;
&#xD;
          -  Patient with simple aortic valve replacement or single / double coronary artery bypass&#xD;
             (CEC duration typically &lt;1h)&#xD;
&#xD;
          -  Patient with chronic autoimmune inflammatory disease, eg lupus, rheumatoid arthritis,&#xD;
             inflammatory bowel disease ...&#xD;
&#xD;
          -  Patient with progressive neoplastic disease&#xD;
&#xD;
          -  Patient with underlying heart disease with left ventricular ejection fraction &lt;30%&#xD;
&#xD;
          -  Pregnant or lactating woman&#xD;
&#xD;
          -  Person deprived of liberty by an administrative or judicial decision or protected&#xD;
             major subject (under tutorship or curatorship)&#xD;
&#xD;
          -  Patient participating in another interventional clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ROUEN Hospital University</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile POURCHER</last_name>
      <phone>02 32 88 82 65</phone>
      <email>Cecile.Pourcher@chu-rouen.fr</email>
    </contact>
    <contact_backup>
      <last_name>Julien BLOT</last_name>
      <phone>02 32 88 82 65</phone>
      <email>julien.blot@chu-rouen.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas Clavier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 25, 2018</study_first_submitted>
  <study_first_submitted_qc>October 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2018</study_first_posted>
  <last_update_submitted>October 25, 2018</last_update_submitted>
  <last_update_submitted_qc>October 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

